Drug Shortage Report for DESFERAL 500MG

Last updated on 2024-06-18 History
Report ID 222962
Drug Identification Number 01981242
Brand name DESFERAL 500MG
Common or Proper name DESFERAL VIALS 500MG 1 X 10
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) DEFEROXAMINE MESYLATE
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR
Packaging size 1 x 10
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-03-21
Actual start date
Estimated end date 2024-06-13
Actual end date 2024-06-17
Shortage status Resolved
Updated date 2024-06-18
Company comments Product is on allocation to minimize patient impact.
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-06-18 English Compare
v10 2024-06-17 French Compare
v9 2024-06-17 English Compare
v8 2024-05-07 French Compare
v7 2024-05-07 English Compare
v6 2024-04-30 French Compare
v5 2024-04-30 English Compare
v4 2024-03-26 French Compare
v3 2024-03-26 English Compare
v2 2024-03-21 French Compare
v1 2024-03-21 English Compare

Showing 1 to 11 of 11